| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/19/2005 | US6881341 Method for separating lactone-containing high-molecular weight compounds |
| 04/14/2005 | WO2005033114A1 Polycyclic macrolactones |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005017126A3 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/14/2005 | WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 04/14/2005 | WO2004112699A3 Mitotic kinesin inhibitors |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080074 Such as (+-)-1,3,4,10b-tetrahydro-7-trifluoromethoxy-pyrazino[2,1-a]isoindol-6(2H)-one for treatment of metabolic disorders, central nervous system disorders, and gastrointestinal disorders |
| 04/14/2005 | DE10337496A1 4-Biphenylsubstituierte-4-substituierte-pyrazolidin-3,5-dione 4-biphenyl-4-substituted-pyrazolidine-3,5-diones |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521747A2 Receptor-type kinase modulators and methods of use |
| 04/13/2005 | EP1521745A1 Method for producing imidazolium salts |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/12/2005 | US6878820 Streptogramin derivatives, their preparation and compositions containing them |
| 04/12/2005 | US6878737 Reversal of multidrug resistance in human colon carcinoma cells |
| 04/12/2005 | CA2259721C Cyclic aryl ethers, thioethers and amines, and method for preparation |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005016935A3 Regioselective synthesis of cci-779 |
| 04/07/2005 | WO2005016873A3 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 04/07/2005 | WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 04/07/2005 | US20050075499 For therapy of cancer |
| 04/07/2005 | US20050075385 Substituted thienoimidazoles useful for disease treatment and prevention |
| 04/07/2005 | US20050075383 Inhibitors of phophodiesterase type-IV |
| 04/07/2005 | US20050075363 Microbiocides, bactericides, fungicides, and antiprotozoa agents; beta-lactamase inhibitors |
| 04/07/2005 | US20050075336 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/07/2005 | US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 04/07/2005 | US20050074632 electrical stability, better charge transporting capability, a high glass transition temperature, and does not crystallize; high-efficiency, low-voltage, high-luminance, long-lifespan; durability; color purity |
| 04/07/2005 | US20050072962 Contains phenoxazine or phenothiazine dye; absorption coefficient, sharp hue, solubility |
| 04/07/2005 | DE10341240A1 Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted Thienoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 04/06/2005 | EP1090012A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP1090011A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP1020459B1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604892A Prodrugs to d-prolines |
| 04/06/2005 | CN1603325A Compound forming heterocyclic azo dye and method for making dye |
| 04/06/2005 | CN1195760C Method for separating lactone-contg. high-molecular weight compounds |
| 04/06/2005 | CN1195759C Process for preparation of benzoxazine derivatives and intermediates therefor |
| 04/05/2005 | US6875865 Selected derivatives of K-252a |
| 04/05/2005 | US6875769 Substituted6,6-hetero-bicyclicderivatives |
| 04/05/2005 | US6875762 Tetracyclic azepinoindole compounds |
| 04/05/2005 | CA2235138C Reverse-turn mimetics and methods relating thereto |
| 04/05/2005 | CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 03/31/2005 | WO2005028483A1 Process for the synthesis of morphinane compounds and intermediates thereof |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | US20050070609 Cyclopentyl modulators of chemokine receptor activity |
| 03/31/2005 | US20050070558 For example, [4-(2,4-Dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetic acid; useful in preventing mast cell degranulation and therefore useful in treatment of diseases induced by activation of A2b receptor and mast cell activation such as asthma, allergic reactions |
| 03/31/2005 | US20050070523 For therapy of bacterial infection in a mammal |
| 03/31/2005 | US20050066453 Spirooxazine series compounds; improved heat stability, light fatigue resistance, sensitivity, and degradation rate; for application to optical memory |
| 03/31/2005 | CA2539659A1 Process for the synthesis of morphinane compounds and intermediates thereof |
| 03/30/2005 | EP1518517A2 Drug-delivery endovascular stent and method for treating restenosis |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/29/2005 | US6872823 Bactericides; chemical intermediates |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/24/2005 | WO2005026173A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 03/24/2005 | WO2005026168A1 Method for preparing cucurbiturils |
| 03/24/2005 | WO2005026161A1 Antibacterial agents |
| 03/24/2005 | WO2005026155A1 Benzimidazole acetonitriles |
| 03/24/2005 | WO2005026145A2 Quinolone antibacterial agents |
| 03/24/2005 | WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | WO2005025293A2 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | WO2004110990A3 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 03/24/2005 | WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| 03/24/2005 | WO2004074249A3 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 03/24/2005 | WO2004064730A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004060283A3 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | WO2004018482A8 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/24/2005 | WO2003099217A3 Methods of treating bacterial infections and diseases associated therewith |
| 03/24/2005 | US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | CA2539160A1 Antibacterial agents |
| 03/24/2005 | CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | CA2537843A1 Method for preparing cucurbiturils |
| 03/24/2005 | CA2537695A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 03/23/2005 | EP1515730A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/23/2005 | CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets |
| 03/22/2005 | US6869971 UCS1025 derivatives |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/17/2005 | WO2005023820A1 Method for the manufacture of thip |
| 03/17/2005 | WO2005023254A1 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same |
| 03/17/2005 | WO2005010015B1 Method of purifying macrolides |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |